Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03317743

Recruitment Status : Active, not recruiting

First Posted : October 23, 2017

Last Update Posted : January 15, 2021

Sponsor:

Collaborators:

IlDong Pharmaceutical Co Ltd

National OncoVenture

Information provided by (Responsible Party):

Idience Co., Ltd.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	December 8, 2020
Estimated Study Completion Date :	June 2021

To Top